Overview and Chemical Properties

5-(2-Chlorophenyl)-1H-pyrazole-3-carboxylic acid is a pyrazole-based heterocyclic compound bearing a carboxylic acid moiety at the 3-position and a 2-chlorophenyl group at the 5-position. The pyrazole ring system is an important pharmacophore found in numerous bioactive molecules, and the carboxylic acid handle facilitates further functionalization via amide coupling, esterification, or decarboxylative transformations.

The 2-chlorophenyl substituent introduces steric and electronic effects that can influence binding interactions in drug–target studies and modulate reactivity in synthetic sequences. Researchers should verify molecular weight, purity, and identity by standard analytical methods (NMR, HPLC, MS) upon receipt.

Safety and Handling Precautions

Before working with 5-(2-Chlorophenyl)-1H-pyrazole-3-carboxylic acid, consult the current Safety Data Sheet (SDS) provided with the product. As with most aromatic carboxylic acid derivatives, standard laboratory precautions apply:

• Personal Protective Equipment (PPE): Wear nitrile gloves, a laboratory coat, and safety glasses or goggles at all times during handling.
• Ventilation: Handle in a well-ventilated fume hood, especially when weighing powdered material, to minimize inhalation of fine particulates.
• Skin and Eye Contact: Avoid direct contact. In case of skin contact, wash thoroughly with soap and water. In case of eye contact, rinse with copious amounts of water and seek medical attention.
• Waste Disposal: Dispose of chemical waste in accordance with local institutional and governmental regulations. Do not pour down the drain.

The compound contains an aryl chloride moiety; while not acutely reactive, appropriate chemical hygiene practices must be maintained throughout all operations.

Stock Solution Preparation Protocol

The following protocol describes preparation of a stock solution for use in downstream synthetic or biochemical assays. Adjust volumes and concentrations to meet specific experimental requirements.

1. Determine required concentration and volume. Calculate the mass of compound needed using the formula: mass (mg) = target concentration (mM) × volume (mL) × molecular weight (g/mol) ÷ 1000.
2. Pre-warm solvent if necessary. For dissolution in DMSO or DMF, gentle warming (37–40 °C water bath) may improve solubility. Do not exceed 60 °C.
3. Weigh accurately. Tare a clean microcentrifuge tube or glass vial on an analytical balance. Transfer the required mass of 5-(2-Chlorophenyl)-1H-pyrazole-3-carboxylic acid carefully to avoid static loss.
4. Add solvent. Add approximately 80% of the target volume of solvent (DMSO is recommended for most applications). Vortex or sonicate briefly until fully dissolved.
5. Adjust to final volume. Add remaining solvent to reach the target volume and mix again.
6. Aliquot and store. Distribute into single-use aliquots in sealed vials to avoid repeated freeze-thaw cycles. Store at –20 °C for long-term stability or at 4 °C for short-term use (up to 1 week). Protect from light and moisture.
7. Quality check. Verify solubility visually; the solution should be clear and free of particulates. For critical applications, confirm identity and concentration by UV-Vis, NMR, or HPLC as appropriate.

Note: Solubility data specific to this compound should be confirmed experimentally or referenced from the product SDS/TDS. The values above represent general guidance for pyrazole carboxylic acid class compounds.

Typical Applications in Research

5-(2-Chlorophenyl)-1H-pyrazole-3-carboxylic acid serves as a versatile building block in several research contexts:

• Medicinal Chemistry: The compound acts as a scaffold for the synthesis of bioactive pyrazole amides and esters. The carboxylic acid group can be coupled with amines via standard coupling reagents (e.g., HATU, EDC/NHS) to generate amide libraries for structure-activity relationship (SAR) studies.
• Heterocyclic Synthesis: The pyrazole core can participate in ring-forming reactions or serve as a precursor to more complex fused heterocycles relevant to agrochemical and pharmaceutical discovery.
• Fragment-Based Drug Discovery (FBDD): Pyrazole carboxylic acids are commonly screened as fragments given their favorable physicochemical properties and synthetic tractability.
• Coordination Chemistry: The carboxylic acid and pyrazole nitrogen atoms can act as ligands for metal coordination, making this compound of interest for catalyst development and metal-organic framework (MOF) research.

Quality Assurance and Troubleshooting

To ensure experimental reproducibility, consider the following quality and troubleshooting guidance:

• Identity Verification: Confirm structure by ¹H NMR and ¹³C NMR, and cross-reference with expected molecular ion by LC-MS (expected [M+H]⁺ based on molecular formula; verify exact mass from product documentation).
• Purity Assessment: Reverse-phase HPLC (C18 column, acetonitrile/water gradient with 0.1% TFA or formic acid) is recommended for purity determination. Consult the certificate of analysis (CoA) provided by Aladdin Scientific for lot-specific purity data.
• Solubility Issues: If precipitation occurs in aqueous buffers, prepare a concentrated stock in DMSO first and dilute into aqueous media. Keep DMSO content below 1% v/v in biological assays to minimize solvent effects.
• Hygroscopicity: Allow sealed vials to equilibrate to room temperature before opening to prevent moisture uptake. Re-seal immediately after use under inert gas (nitrogen or argon) if long-term storage is required.
• Tautomerism: Pyrazole-3-carboxylic acids can exist as tautomers (1H vs. 2H forms) in solution; this is normal and generally does not affect reactivity in standard synthetic applications. Consult NMR literature for characterization details.